gene synthesis Molecular Assemblies Extends Series A Financing Round by $11.8M The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund. Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector. DNA Script Preparing Launch of Benchtop Enzymatic Synthesizer for 'DNA on Demand' Premium The Syntax instrument, available later this year, will initially be able to make batches of 96 oligos of 60-mer length at a time with same-day turnaround. Twist Bioscience Reveals MRD Testing Applications, Regeneron Genotyping Project Premium In addition to discussing Twist's liquid biopsy, NGS-based genotyping and SARS-CoV-2 NGS panel, CEO Emily Leproust touted efforts on DNA data storage. Twist Bioscience Fiscal Q1 Revenues Grow 64 Percent; JP Morgan Downgrades to Underweight The firm reported $28.2 million in revenues for the three months ended Dec. 31, 2020, beating consensus Wall Street estimates on the top and bottom lines. Jan 4, 2021 Evercore ISI Downgrades Twist Bioscience to In-Line Rating Dec 2, 2020 Twist Bioscience Proposes $250M Public Offering Nov 23, 2020 Twist Bioscience Plots Continued Growth With NGS Product Push Into Ag-Bio, Cancer Dx Premium Nov 23, 2020 Twist Bioscience Fiscal Q4 Revenues More Than Double Oct 20, 2020 SVB Leerink Initiates Coverage of Twist Bioscience With Market Perform Rating Aug 6, 2020 Twist Bioscience Q3 Revenues Grow 56 Percent Jul 29, 2020 France's DNA Script Extends Series B Financing Round to $89M Jun 4, 2020 Twist Bioscience Prices $100M Stock Offering May 21, 2020 Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab Premium May 7, 2020 Twist Bioscience Q2 Revenues Increase 42 Percent Mar 2, 2020 Evonetix Closes £23M Series B Financing Feb 19, 2020 Twist Bioscience Announces $100M Public Stock Offering Feb 7, 2020 With Agilent Litigation Gone, Twist Bioscience Sees Long-Term Growth in Biopharma, DNA Data Storage Premium Feb 6, 2020 Twist Bioscience Settles With Agilent, Reports 49 Percent Rise in Fiscal Q1 Revenues Feb 6, 2020 Twist Bioscience Shares Soar on Speculation of Lawsuit Settlement With Agilent Jan 13, 2020 Evonetix, Imec Collaborate on Silicon Chip Manufacturing for DNA Synthesis Dec 12, 2019 Twist Bioscience Teases Products for Liquid Biopsy Market, Biopharma Collaborations Premium Oct 10, 2019 Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry Premium Oct 2, 2019 Molecular Assemblies Raising Cash, Awareness for Enzymatic DNA Synthesis Premium Sep 9, 2019 SGI-DNA Raises $25M in Series A Financing Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.